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We investigated Japanese encephalitis virus (JEV) preva-
lence in high-altitude regions of Tibet, China, by using stan-
dard assays to test mosquitoes, pigs, and humans. Results 
confirmed that JEV has spread to these areas. Disease 
prevention and control strategies should be used along 
with surveillance to limit spread of JEV in high-altitude 
regions of Tibet.
Japanese encephalitis virus (JEV) is the causative agent of a viral encephalitis that is a major public health threat 
in most parts of East and Southeast Asia (1,2). Tibet, China, 
has been considered a nonepidemic area for JEV because 
its mean elevation is >3,100 m, and the relatively low tem-
peratures at the elevation do not support JEV transmission 
between mosquitoes, reservoirs, and amplifying hosts (2). 
However, this situation in Tibet has probably changed due 
to increased pig farming in the region and increased travel 
between Tibet and areas where JEV is endemic (3–5). To 
test our hypothesis, we tested for JEV in mosquitoes and 
measured JEV-specific IgM in swine and humans living in 
a high-altitude region of Tibet.
We conducted the study in Nyingchi District (elevation 
3,100 m) in southeastern Tibet. The mean temperature dur-
ing the study period ranged from 11.3°C to 22.4°C. Swine 
and humans included in the study had no history of travel 
to JEV-endemic areas.
To determine whether mosquitoes were infected with 
JEV, we collected 8,330 mosquitoes (belonging to 9 gen-
era and 4 species) near pig sties and human residences in 
Nyingchi, Mainling, and Gongbo’gyamda Counties. From 
those 8,330 mosquitoes, we chose 2,655 JEV vector mos-
quitoes: 330 (3.96%) Culex tritaeniorhynchus, 45 (0.54%) 
C. bitaeniorhynchus, and 2,280 (27.37%) C. pipiens 
mosquitoes. To detect JEV, we used the TIANamp Vi-
rus DNA/RNA Kit (TianGen, Beijing, China) with pools 
of whole-body Culex mosquito extracts; we analyzed the 
samples by reverse transcription PCR (RT-PCR) amplifica-
tion using the Quant One-Step RT-PCR Kit (TianGen) and 
primers specific for the JEV nonstructural 1 gene (6). Of 11 
C. tritaeniorhynchus and 69 C. pipiens mosquito pools, 7 
(63.6%) and 2 (2.9%), respectively, were positive for JEV 
by RT-PCR; the 1 C. bitaeniorhynchus mosquito pool was 
not positive for JEV (Table).
To determine the origin of JEV in pigs, we collected 
a total of 454 serum samples from 1- to 6-month-old pigs 
from local slaughterhouses. We analyzed the samples for 
JEV IgM by using a commercial ELISA kit as previously 
described (7). We used the χ2 test and SPSS software (SPSS 
Inc., Chicago, IL, USA) to analyze all data; p<0.05 was 
considered significant. 
The overall seroprevalence of JEV IgM in the pigs 
was 5.07%. The percentage of positive samples from Ny-
ingchi County (3.25%) was significantly lower than that 
from Mainling Country (7.81%); no serum samples from 
Gongbo’gyamda County were JEV-positive (Table). The 
difference in seroprevalence of JEV in male (4.62%) and 
female (5.67%) pigs was not statistically significant.
To determine the prevalence of JEV infection among 
persons, we collected blood samples from 364 healthy 
human volunteers residing in the 3 counties and ana-
lyzed the samples for JEV IgM by using a commercial 
ELISA kit as previously described (8). JEV seropreva-
lence was11.71% for the 1- to 23-year-old age group, 
13.43% for the 24- to 45-year-old age group, and 4.20% 
for the >45-year-old age group (Table). Seroprevalence 
was significantly higher among persons 1–23 or 24–45 
years of age, compared with persons >45 years of age, 
suggesting that 1) younger persons may have greater ex-
posure risks than persons >45 years of age, 2) JEV is a 
relative new introduction in the area as a result of the 
changing (i.e., warmer) climate, and 3) younger persons 
may travel more frequently than older persons to lower 
elevations where JEV is endemic. An IgG-based survey 
might identify more JEV disease, even in persons who 
showed no symptoms of the disease. 
JEV seroprevalence was significantly higher in ru-
ral populations (6.87%) compared with urban population 
(3.02%). The spread of JEV may be increased by amplify-
ing hosts (pigs); thus, the lower prevalence of JEV in urban 
residents may be associated with a lower number of pig 
farms in urban areas compared with rural villages in Ny-
ingchi District.
In conclusion, we found that JEV infection is prevalent 
in a high-altitude region of Tibet that was previously con-
sidered to be free from JEV. Factors such as increased tour-
ism (9), increased mean summer temperatures, increased 
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movement between the study area and nearby JEV-
endemic regions, inadequate public health systems, in-
creased pig farming, increased migration of water birds, 
and the absence of a compulsory immunization policy 
may contribute to emergence of this disease (3,4,9,10). 
Disease prevention and control strategies should be used 
along with surveillance to limit the spread of JEV in high-
altitude regions of Tibet.
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Table. Japanese encephalitis virus IgM–positive pigs and humans and Japanese encephalitis virus-positive Culex mosquitoes in 
Nyingchi District, Tibet, China, 2015* 
Category, variable 
No. IgM positive/no. tested (%) Total no. positive/total no. tested 
(%) Male pig or person Female pig or person 
Pigs    
 County location    
  Nyingchi 3/146 (2.05) 5/100 (5.00) 8/246 (3.25) 
  Mainling 9/105 (8.57) 6/87 (6.90) 15/192 (7.81) 
  Gongbo'gyamda 0/9 0/7 0/16 
  Total 12/260 (4.62) 11/194 (5.67) 23/454 (5.07) 
Humans    
 County location    
  Nyingchi 6/66 (9.09) 11/93 (11.83) 17/159 (10.69) 
  Mainling 8/58 (13.79) 9/65 (13.85) 17/123 (13.82) 
  Gongbo’gyamda 1/43 (2.33) 1/39 (2.56) 2/82 (2.44) 
  Total 15/167 (8.98) 21/197 (10.66) 36/364 (9.89) 
 Age group, y     
  1–23 6/57 (10.53) 7/54 (12.96) 13/111 (11.71) 
  24–45 7/54 (12.96) 11/80 (13.75) 18/134 (13.43) 
  >45 2/56 (3.57) 3/63 (4.76) 5/119 (4.20) 
  Total 15/167 (8.98) 21/197 (10.66) 36/364 (9.89) 
Culex mosquitoes†    
 C. tritaeniorhynchus ND ND 7/11 (0.636)‡ 
 C. bitaeniorhynchus ND ND 0/1‡ 
 C. pipiens ND ND 2/69 (0.029)‡ 
*Except as indicated, data are no. (%). ND, Not done. 
†Denominator indicates no. in pool. 
‡Maximum likelihood estimates (no. pools positive for JEV by reverse transcription PCR). 
 
